CRANBURY, N.J.--(BUSINESS WIRE)--OncLive® is pleased to announce that yesterday it honored 15 remarkable cancer care pioneers during the 8th Annual Giants of Cancer Care® Awards Ceremony. The virtual awards ceremony was held during the 38th Annual CFS®: Innovative Cancer Therapy for Tomorrow®, hosted by Physicians’ Education Resource®, LLC (PER®).
The 2020 class of Giants of Cancer Care® inductees hail from locales around the globe, including Lagos, Nigeria; Amsterdam; Brussels; and Philadelphia. This year’s class marks the eighth consecutive year that OncLive® has saluted the physician-scientists who are shaping oncology practice, bringing the total number of honorees recognized through the Giants of Cancer Care® program to 113.
The award recipients of this year’s class were chosen from a field of more than 800 clinicians and investigators - a record number of peer nominations representing a 32% increase over 2019. A seven-member steering committee winnowed the nominees down to 75 finalists and an elite selection committee of more than 120 hematologists and oncologists then voted to choose the 2020 honorees, which includes 7 women, the most for a single class in the history of the program. Click here to view the on-demand version of the ceremony.
To maintain the continued momentum of recognizing top oncologists and researchers who have made extraordinary advances in oncology research and clinical practice, nominations for the 2021 Giants of Cancer Care® program are now open through February 28, 2021.
OncLive® began the Giants of Cancer Care® program in 2013 to honor clinicians and investigators who have contributed to advancements in the understanding of cancer and the treatment of patients. Recipients must possess selflessness, compassion for patients and a desire to understand and develop life-changing anticancer treatments.
“Congratulations to the 2020 class of Giants of Cancer Care®,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of OncLive®. “This year’s Giants inductees represent a group of remarkably talented scientists and physicians who have made exceptional contributions in the field of oncology worldwide. As we enter our ninth year, we can proudly note that with the induction of our 2020 class, we have surpassed our 100 physician-member mark and look forward to honoring the next powerhouse class of oncology leaders.”
For more information and to submit a nomination, click here.
Supporters of the 2020 program included Pfizer, Incyte, SeaGen, and Athenex Oncology.
OncLive® is a digital platform of resources offering oncology professionals the information they need to provide the best patient care. OncLive® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.
About Giants of Cancer Care®
Giants of Cancer Care® celebrates the achievements of leading researchers and educators whose discoveries have helped propel the field of oncology forward and established the building blocks for future advances. Every year, a selection committee of more than 120 eminent oncologists, researchers and clinicians chooses honorees from several types of tumor and specialty categories.